Journals & Subscriptions

Journal of Commerical Biotechnology 

 

journal

  • Free 1 year digital institutional subscription for new MassBio members (> $1100 value)
  • 20% off personal or institutional subscriptions for existing MassBio members

“Like a Harvard Business Review for biotechnology companies”

— Australian School of Business

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up to date with current issues and industry trends. 

Yali Friedman, Publisher and Chief Editor

editor@commercialbiotechnology.com

 

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

More details and sample papers at http://CommercialBiotechnology.com/

 

About MassBio

MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.

Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.

image of rss iconLatest Updates